PODD Stock to Gain From Launch of Omnipod 5 With Abbott's CGM in US
Insulet (PODD) ZACKS·2024-11-23 00:15
Insulet Corp. (PODD) announced that its Omnipod 5 Automated Insulin Delivery (“AID”) System is now compatible with Abbott’s (ABT) FreeStyle Libre 2 Plus continuous glucose monitoring (CGM) sensor in the United States. The latest development represents a significant step forward in the company’s efforts to expand access to its innovative, tubeless Omnipod 5 AID System for more people.In August 2024, the FDA cleared Omnipod 5 for use by people with type 2 diabetes (18 years and above), expanding the technolog ...